Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

441
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
441
T Cell Types and Functions01:24

T Cell Types and Functions

703
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
703
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

705
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
705
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

812
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
812
Inflammatory Response01:28

Inflammatory Response

1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Vertebrate Genomes Project Phase I: A global reference genome resource.

bioRxiv : the preprint server for biology·2026
Same author

Chromosome-level assembly of the Critically Endangered school shark, Galeorhinus galeus (Linnaeus, 1758).

Scientific data·2026
Same author

Multicohort analysis unveils axon guidance pathways linking small for gestational age to spirometric restriction.

Nature communications·2026
Same author

HCA2 Receptors in Lymphocytes and Keratinocytes Affect Murine Contact Allergic Inflammation.

Experimental dermatology·2026
Same author

Molecular and Functional Platelet Abnormalities in Myeloproliferative Neoplasms.

Cells·2026
Same author

Auto-inducible expression of chimeric antigen receptor T cells using the NR4A1 promoter.

Immunology and cell biology·2026

Related Experiment Video

Updated: May 17, 2025

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.5K

Interleukin-4 modulates type I interferon to augment antitumor immunity.

Hannah V Newnes1,2, Jesse D Armitage1,2, Anthony C Buzzai3

  • 1School of Biomedical Sciences, The University of Western Australia, Perth, Australia.

Science Advances
|May 14, 2025
PubMed
Summary
This summary is machine-generated.

Type I interferon (IFN-I) shows complex roles in melanoma. Enhancing antitumor immunity requires balancing IFN-I signaling with interleukin-4 (IL-4) to overcome therapy resistance.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

5.9K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.3K

Related Experiment Videos

Last Updated: May 17, 2025

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.5K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

5.9K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.3K

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Metastatic melanoma presents significant therapeutic challenges, often linked to tumor microenvironment complexity.
  • Intratumoral type I interferon (IFN-I) has a dual role, potentially improving outcomes or promoting tumor growth.
  • Understanding the specific roles of IFN-I subtypes is crucial for effective cancer immunotherapy.

Purpose of the Study:

  • To investigate the paradoxical effects of different type I interferon (IFN-I) subtypes in a murine melanoma model.
  • To explore the interplay between IFN-I signaling and type 2 inflammation in controlling tumor growth.
  • To identify strategies for enhancing T cell-mediated antitumor immunity in nonresponsive solid tumors.

Main Methods:

  • Engineering murine B16 melanoma cells to overexpress various IFN-I subtypes.
  • Characterizing tumor immune phenotypes using RNA sequencing.
  • Restoring T cell-mediated rejection by introducing interleukin-4 (IL-4) via ectopic expression or adoptive T cell therapy.

Main Results:

  • Overexpression of certain IFN-I subtypes led to a spectrum of tumor outcomes.
  • Potent IFN-I signaling with diminished type 2 inflammation did not achieve durable tumor control.
  • Interleukin-4 (IL-4) introduction restored T cell-mediated tumor rejection in preclinical models.

Conclusions:

  • The IFN-I/IL-4 axis is critical for promoting effective antitumor immunity.
  • Targeting this axis could offer new therapeutic strategies for refractory solid tumors.
  • Stratification of patients based on this axis may improve immunotherapy response.